메뉴 건너뛰기




Volumn 8, Issue 3, 2010, Pages 293-300

The importance of early diagnosis and treatment in peripheral arterial disease: Insights from the PARTNERS and REACH registries

Author keywords

Ankle brachial index; Atherosclerosis; Cardiovascular disease; Peripheral arterial disease; Secondary prevention

Indexed keywords

(1 BUTYLAMINO 3 METHYLBUTYL)(1 PYRROLIDINYL) KETONE; ACETYLSALICYLIC ACID; AMFEBUTAMONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CILOSTAZOL; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRIC ACID DERIVATIVE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO; SIMVASTATIN;

EID: 77952922177     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016110791112304     Document Type: Article
Times cited : (23)

References (63)
  • 1
    • 39749191084 scopus 로고    scopus 로고
    • Heart disease and stroke statistics--2008 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics--2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008; 117: e25-146.
    • (2008) Circulation , vol.117
    • Rosamond, W.1    Flegal, K.2    Furie, K.3
  • 2
    • 33747449559 scopus 로고    scopus 로고
    • Peripheral arterial disease: Morbidity and mortality implications
    • Golomb BA, Dang TT, Criqui MH. Peripheral arterial disease: morbidity and mortality implications. Circulation 2006; 114: 688-99.
    • (2006) Circulation , vol.114 , pp. 688-699
    • Golomb, B.A.1    Dang, T.T.2    Criqui, M.H.3
  • 3
    • 33645522876 scopus 로고    scopus 로고
    • ACC/AHA 2005 guide-lines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): Executive summary
    • A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation
    • Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 guide-lines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): executive summary. A collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease) endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. J Am Coll Cardiol 2006; 47: 1239-312.
    • (2006) J Am Coll Cardiol , vol.47 , pp. 1239-1312
    • Hirsch, A.T.1    Haskal, Z.J.2    Hertzer, N.R.3
  • 4
    • 0026501734 scopus 로고
    • Mortality over a period of 10 years in patients with peripheral arterial disease
    • Criqui MH, Langer RD, Fronek A, et al. Mortality over a period of 10 years in patients with peripheral arterial disease. N Engl J Med 1992; 326: 381-6.
    • (1992) N Engl J Med , vol.326 , pp. 381-386
    • Criqui, M.H.1    Langer, R.D.2    Fronek, A.3
  • 6
    • 33751003540 scopus 로고    scopus 로고
    • Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events
    • Agnelli G, Cimminiello C, Meneghetti G, Urbinati S. Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events. J Thromb Haemost 2006; 4: 2599-606.
    • (2006) J Thromb Haemost , vol.4 , pp. 2599-2606
    • Agnelli, G.1    Cimminiello, C.2    Meneghetti, G.3    Urbinati, S.4
  • 7
    • 30444453441 scopus 로고    scopus 로고
    • International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis
    • Bhatt DL, Steg PG, Ohman EM, et al. International prevalence, recognition, and treatment of cardiovascular risk factors in outpatients with atherothrombosis. JAMA 2006; 295: 180-9.
    • (2006) JAMA , vol.295 , pp. 180-189
    • Bhatt, D.L.1    Steg, P.G.2    Ohman, E.M.3
  • 8
    • 0033003013 scopus 로고    scopus 로고
    • Lower-extremity arteriosclerosis as a reflection of a systemic process: Implications for concomitant coronary and carotid disease
    • Dormandy J, Heeck L, Vig S. Lower-extremity arteriosclerosis as a reflection of a systemic process: implications for concomitant coronary and carotid disease. Semin Vasc Surg 1999; 12: 118-22.
    • (1999) Semin Vasc Surg , vol.12 , pp. 118-122
    • Dormandy, J.1    Heeck, L.2    Vig, S.3
  • 9
    • 34250758640 scopus 로고    scopus 로고
    • The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients
    • Poredos P, Jug B. The prevalence of peripheral arterial disease in high risk subjects and coronary or cerebrovascular patients. Angiology 2007; 58: 309-15.
    • (2007) Angiology , vol.58 , pp. 309-315
    • Poredos, P.1    Jug, B.2
  • 10
    • 42349086464 scopus 로고    scopus 로고
    • Risk factor profile and management of cerebrovascular patients in the REACH Registry
    • Rother J, Alberts MJ, Touze E, et al. Risk factor profile and management of cerebrovascular patients in the REACH Registry. Cerebrovasc Dis 2008; 25: 366-74.
    • (2008) Cerebrovasc Dis , vol.25 , pp. 366-374
    • Rother, J.1    Alberts, M.J.2    Touze, E.3
  • 11
    • 0034688194 scopus 로고    scopus 로고
    • Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
    • Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000; 342: 145-53.
    • (2000) N Engl J Med , vol.342 , pp. 145-153
    • Yusuf, S.1    Sleight, P.2    Pogue, J.3    Bosch, J.4    Davies, R.5    Dagenais, G.6
  • 12
    • 0035206979 scopus 로고    scopus 로고
    • PAD awareness, risk, and treatment: New resources for survival--the USA PARTNERS program
    • Hirsch AT, Hiatt WR. PAD awareness, risk, and treatment: new resources for survival--the USA PARTNERS program. Vasc Med 2001; 6: 9-12.
    • (2001) Vasc Med , vol.6 , pp. 9-12
    • Hirsch, A.T.1    Hiatt, W.R.2
  • 13
    • 0035913589 scopus 로고    scopus 로고
    • Peripheral arterial disease detection, awareness, and treatment in primary care
    • Hirsch AT, Criqui MH, Treat-Jacobson D, et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 2001; 286: 1317-24.
    • (2001) JAMA , vol.286 , pp. 1317-1324
    • Hirsch, A.T.1    Criqui, M.H.2    Treat-Jacobson, D.3
  • 14
    • 42649098207 scopus 로고    scopus 로고
    • The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program
    • Regensteiner JG, Hiatt WR, Coll JR, et al. The impact of peripheral arterial disease on health-related quality of life in the Peripheral Arterial Disease Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) Program. Vasc Med 2008; 13: 15-24.
    • (2008) Vasc Med , vol.13 , pp. 15-24
    • Regensteiner, J.G.1    Hiatt, W.R.2    Coll, J.R.3
  • 15
    • 13444312019 scopus 로고    scopus 로고
    • Utility and barriers to performance of the ankle brachial index in primary care practice
    • Mohler ER III, Treat-Jacobson D, Reilly MP, et al. Utility and barriers to performance of the ankle brachial index in primary care practice. Vasc Med 2004; 9: 253-60.
    • (2004) Vasc Med , vol.9 , pp. 253-260
    • Mohler III, E.R.1    Treat-Jacobson, D.2    Reilly, M.P.3
  • 17
    • 67349127553 scopus 로고    scopus 로고
    • Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry
    • Cacoub PP, Abola MTB, Baumgartner I, et al. Cardiovascular risk factor control and outcomes in peripheral artery disease patients in the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Athesclerosis 2009; 204: e86-92.
    • (2009) Athesclerosis , vol.204
    • Cacoub, P.P.1    Abola, M.T.B.2    Baumgartner, I.3
  • 18
    • 70549106493 scopus 로고    scopus 로고
    • Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US out-patients with peripheral arterial disease: Insights from the reduction of atherothrombosis for continued health (REACH) Registry
    • Meadows TA, Bhatt DL, Hirsch AT, et al. Ethnic differences in the prevalence and treatment of cardiovascular risk factors in US out-patients with peripheral arterial disease: insights from the reduction of atherothrombosis for continued health (REACH) Registry. Am Heart J 2009; 158: 1038-45.
    • (2009) Am Heart J , vol.158 , pp. 1038-1045
    • Meadows, T.A.1    Bhatt, D.L.2    Hirsch, A.T.3
  • 19
    • 33947533514 scopus 로고    scopus 로고
    • One-year cardiovascular event rates in outpatients with atherothrombosis
    • Steg PG, Bhatt DL, Wilson PW, et al. One-year cardiovascular event rates in outpatients with atherothrombosis. JAMA 2007; 297: 1197-206.
    • (2007) JAMA , vol.297 , pp. 1197-1206
    • Steg, P.G.1    Bhatt, D.L.2    Wilson, P.W.3
  • 20
    • 77952949639 scopus 로고    scopus 로고
    • Two-year cardiovascular event rates of the cerebrovascular disease subpopulation within the REduction of Atherothrombosis for Continued Health (REACH) Registry
    • Rother J, Mas JL, Touze E, et al. Two-year cardiovascular event rates of the cerebrovascular disease subpopulation within the REduction of Atherothrombosis for Continued Health (REACH) Registry. XVII European Stroke Conference, Nice, France, May 13-16, 2008.
    • (2008) XVII European Stroke Conference, Nice, France, May , pp. 13-16
    • Rother, J.1    Mas, J.L.2    Touze, E.3
  • 21
    • 24944529933 scopus 로고    scopus 로고
    • Risk factors, medical therapies and perioperative events in limb salvage surgery: Observations from the PREVENT III multicenter trial
    • Conte MS, Bandyk DF, Clowes AW, Moneta GL, Namini H, Seely L. Risk factors, medical therapies and perioperative events in limb salvage surgery: observations from the PREVENT III multicenter trial. J Vasc Surg 2005; 45: 456-64.
    • (2005) J Vasc Surg , vol.45 , pp. 456-464
    • Conte, M.S.1    Bandyk, D.F.2    Clowes, A.W.3    Moneta, G.L.4    Namini, H.5    Seely, L.6
  • 22
    • 33746741040 scopus 로고    scopus 로고
    • Peripheral arterial disease vs. other localizations of vascular disease: The ATTEST study
    • Blacher J, Cacoub P, Luizy F, et al. Peripheral arterial disease vs. other localizations of vascular disease: the ATTEST study. J Vasc Surg 2006; 44: 314-8.
    • (2006) J Vasc Surg , vol.44 , pp. 314-318
    • Blacher, J.1    Cacoub, P.2    Luizy, F.3
  • 23
    • 42649133162 scopus 로고    scopus 로고
    • Associations between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication
    • Daskalopoulou SS, Pathmarajah M, Kakkos SK, et al. Associations between ankle-brachial index and risk factor profile in patients newly diagnosed with intermittent claudication. Circ J 2008; 72: 441-8.
    • (2008) Circ J , vol.72 , pp. 441-448
    • Daskalopoulou, S.S.1    Pathmarajah, M.2    Kakkos, S.K.3
  • 24
    • 33847668445 scopus 로고    scopus 로고
    • Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation
    • Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM, Jr. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation. Ann Vasc Surg 2007; 21: 163-6.
    • (2007) Ann Vasc Surg , vol.21 , pp. 163-166
    • Bianchi, C.1    Montalvo, V.2    Ou, H.W.3    Bishop, V.4    Abou-Zamzam Jr., A.M.5
  • 25
    • 0029093782 scopus 로고
    • Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis
    • Gardner AW, Poehlman ET. Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 1995; 274: 975-80.
    • (1995) JAMA , vol.274 , pp. 975-980
    • Gardner, A.W.1    Poehlman, E.T.2
  • 26
    • 0023188638 scopus 로고
    • Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality
    • Jonason T, Bergstrom R. Cessation of smoking in patients with intermittent claudication. Effects on the risk of peripheral vascular complications, myocardial infarction and mortality. Acta Med Scand 1987; 221: 253-60.
    • (1987) Acta Med Scand , vol.221 , pp. 253-260
    • Jonason, T.1    Bergstrom, R.2
  • 28
    • 32644435452 scopus 로고    scopus 로고
    • Effects of low-carbohydrate vs. low-fat diets on weight loss and cardiovascular risk factors: A meta-analysis of randomized controlled trials
    • Nordmann AJ, Nordmann A, Briel M, et al. Effects of low-carbohydrate vs. low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 285-93.
    • (2006) Arch Intern Med , vol.166 , pp. 285-293
    • Nordmann, A.J.1    Nordmann, A.2    Briel, M.3
  • 29
    • 0030813119 scopus 로고    scopus 로고
    • The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease
    • Hirsch AT, Treat-Jacobson D, Lando HA, Hatsukami DK. The role of tobacco cessation, antiplatelet and lipid-lowering therapies in the treatment of peripheral arterial disease. Vasc Med 1997; 2: 243-51.
    • (1997) Vasc Med , vol.2 , pp. 243-251
    • Hirsch, A.T.1    Treat-Jacobson, D.2    Lando, H.A.3    Hatsukami, D.K.4
  • 31
    • 33746189864 scopus 로고    scopus 로고
    • Relationship of smoking and smoking cessation with ankle-to-arm blood pressure index in elderly Japanese men
    • Cui R, Iso H, Yamagishi K, et al. Relationship of smoking and smoking cessation with ankle-to-arm blood pressure index in elderly Japanese men. Eur J Cardiovasc Prev Rehabil 2006; 13: 243-8.
    • (2006) Eur J Cardiovasc Prev Rehabil , vol.13 , pp. 243-248
    • Cui, R.1    Iso, H.2    Yamagishi, K.3
  • 32
    • 34249914794 scopus 로고    scopus 로고
    • Statins and peripheral arterial disease: Effects on claudication, disease progression, and prevention of cardiovascular events
    • Coppola G, Novo S. Statins and peripheral arterial disease: effects on claudication, disease progression, and prevention of cardiovascular events. Arch Med Res 2007; 38: 479-88.
    • (2007) Arch Med Res , vol.38 , pp. 479-488
    • Coppola, G.1    Novo, S.2
  • 33
    • 49649110690 scopus 로고    scopus 로고
    • The role of statin drugs in the management of the peripheral vascular patient
    • Samson RH. The role of statin drugs in the management of the peripheral vascular patient. Vasc Endovasc Surg 2008; 42: 352-66.
    • (2008) Vasc Endovasc Surg , vol.42 , pp. 352-366
    • Samson, R.H.1
  • 34
    • 67649595710 scopus 로고    scopus 로고
    • Vascular protection in peripheral artery disease: Systematic review and modeling study
    • Hackam DG, Sutan NM, Criqui MH. Vascular protection in peripheral artery disease: systematic review and modeling study. Heart 2009; 95: 1098-102.
    • (2009) Heart , vol.95 , pp. 1098-1102
    • Hackam, D.G.1    Sutan, N.M.2    Criqui, M.H.3
  • 35
    • 0347093525 scopus 로고    scopus 로고
    • The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease
    • Youssef F, Gupta P, Seifalian AM, Myint F, Mikhailidis DP, Hamilton G. The effect of short-term treatment with simvastatin on renal function in patients with peripheral arterial disease. Angiology 2004; 55: 53-62.
    • (2004) Angiology , vol.55 , pp. 53-62
    • Youssef, F.1    Gupta, P.2    Seifalian, A.M.3    Myint, F.4    Mikhailidis, D.P.5    Hamilton, G.6
  • 36
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo-controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360: 7-22.
    • (2002) Lancet , vol.360 , pp. 7-22
  • 37
    • 33747052530 scopus 로고    scopus 로고
    • Can statins reduce perioperative morbidity and mortality in patients under-going non-cardiac vascular surgery?
    • Paraskevas KI, Liapis CD, Hamilton G, Mikhailidis DP. Can statins reduce perioperative morbidity and mortality in patients under-going non-cardiac vascular surgery? Eur J Vasc Endovasc Surg 2006; 32: 286-93.
    • (2006) Eur J Vasc Endovasc Surg , vol.32 , pp. 286-293
    • Paraskevas, K.I.1    Liapis, C.D.2    Hamilton, G.3    Mikhailidis, D.P.4
  • 38
    • 25644456061 scopus 로고    scopus 로고
    • The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery
    • Ward RP, Leeper NJ, Kirkpatrick JN, Lang RM, Sorrentino MJ, Williams KA. The effect of preoperative statin therapy on cardiovascular outcomes in patients undergoing infrainguinal vascular surgery. Int J Cardiol 2005; 104: 264-8.
    • (2005) Int J Cardiol , vol.104 , pp. 264-268
    • Ward, R.P.1    Leeper, N.J.2    Kirkpatrick, J.N.3    Lang, R.M.4    Sorrentino, M.J.5    Williams, K.A.6
  • 39
    • 0025992650 scopus 로고
    • Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials
    • Radack K, Deck C. Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials. Arch Intern Med 1991; 151: 1769-76.
    • (1991) Arch Intern Med , vol.151 , pp. 1769-1776
    • Radack, K.1    Deck, C.2
  • 40
    • 0035371384 scopus 로고    scopus 로고
    • Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease
    • Aronow WS, Ahn C. Effect of beta blockers on incidence of new coronary events in older persons with prior myocardial infarction and symptomatic peripheral arterial disease. Am J Cardiol 2001; 87: 1284-6.
    • (2001) Am J Cardiol , vol.87 , pp. 1284-1286
    • Aronow, W.S.1    Ahn, C.2
  • 41
    • 1542299133 scopus 로고    scopus 로고
    • The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease
    • Jagroop IA, Matsagas MI, Geroulakos G, Mikhailidis DP. The effect of clopidogrel, aspirin and both antiplatelet drugs on platelet function in patients with peripheral arterial disease. Platelets 2004; 15: 117-25.
    • (2004) Platelets , vol.15 , pp. 117-125
    • Jagroop, I.A.1    Matsagas, M.I.2    Geroulakos, G.3    Mikhailidis, D.P.4
  • 42
    • 0037065502 scopus 로고    scopus 로고
    • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients
    • Antithrombotic Trialists' Collaboration
    • Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324: 71-86.
    • (2002) BMJ , vol.324 , pp. 71-86
  • 43
    • 0030590746 scopus 로고    scopus 로고
    • A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE)
    • CAPRIE Steering Committee
    • CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel vs. aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-39.
    • (1996) Lancet , vol.348 , pp. 1329-1339
  • 44
    • 65549105821 scopus 로고    scopus 로고
    • Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: A meta-analysis of randomized trial
    • Berger JS, Krantz MJ, Kittelson JM, Hiatt WR. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trial. JAMA 2009; 301: 1909-19.
    • (2009) JAMA , vol.301 , pp. 1909-1919
    • Berger, J.S.1    Krantz, M.J.2    Kittelson, J.M.3    Hiatt, W.R.4
  • 45
    • 0036592798 scopus 로고    scopus 로고
    • Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100
    • Roller RE, Dorr A, Ulrich S, Pilger E. Effect of aspirin treatment in patients with peripheral arterial disease monitored with the platelet function analyzer PFA-100. Blood Coagul Fibrinolysis 2002; 13: 277-81.
    • (2002) Blood Coagul Fibrinolysis , vol.13 , pp. 277-281
    • Roller, R.E.1    Dorr, A.2    Ulrich, S.3    Pilger, E.4
  • 46
    • 33745325634 scopus 로고    scopus 로고
    • Overcoming aspirin resistance: Increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease
    • Wong S, Morel-Kopp MC, Chen Q, Appleberg M, Ward CM, Lewis DR. Overcoming aspirin resistance: increased platelet inhibition with combination aspirin and clopidogrel and high dose aspirin therapy in aspirin resistant patients with peripheral vascular disease. Thromb Haemost 2006; 95: 1042-3.
    • (2006) Thromb Haemost , vol.95 , pp. 1042-1043
    • Wong, S.1    Morel-Kopp, M.C.2    Chen, Q.3    Appleberg, M.4    Ward, C.M.5    Lewis, D.R.6
  • 47
    • 69249211258 scopus 로고    scopus 로고
    • Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up
    • Linnemann B, Prochow S, Mani H, Schwonberg J, Lindhoff-Last E. Variability of non-response to aspirin in patients with peripheral arterial occlusive disease during long-term follow-up. Ann Hematol 2009; 88: 979-88.
    • (2009) Ann Hematol , vol.88 , pp. 979-988
    • Linnemann, B.1    Prochow, S.2    Mani, H.3    Schwonberg, J.4    Lindhoff-Last, E.5
  • 48
    • 9844224482 scopus 로고    scopus 로고
    • Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty
    • Mueller MR, Salat A, Stangl P, et al. Variable platelet response to low-dose ASA and the risk of limb deterioration in patients submitted to peripheral arterial angioplasty. Thromb Haemost 1997; 78: 1003-7.
    • (1997) Thromb Haemost , vol.78 , pp. 1003-1007
    • Mueller, M.R.1    Salat, A.2    Stangl, P.3
  • 49
    • 29244439006 scopus 로고    scopus 로고
    • Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: A randomized crossover trial
    • Eikelboom JW, Hankey GJ, Thom J, et al. Enhanced antiplatelet effect of clopidogrel in patients whose platelets are least inhibited by aspirin: a randomized crossover trial. J Thromb Haemost 2005; 3: 2649-55.
    • (2005) J Thromb Haemost , vol.3 , pp. 2649-2655
    • Eikelboom, J.W.1    Hankey, G.J.2    Thom, J.3
  • 50
    • 33645861080 scopus 로고    scopus 로고
    • Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events
    • Bhatt DL, Fox KA, Hacke W, et al. Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events. N Engl J Med 2006; 354: 1706-17.
    • (2006) N Engl J Med , vol.354 , pp. 1706-1717
    • Bhatt, D.L.1    Fox, K.A.2    Hacke, W.3
  • 52
  • 53
    • 77952918209 scopus 로고    scopus 로고
    • Belch J on behalf of the CASPAR investigators. Effect of adding clopidogrel to aspirin on the success of below knee arterial bypass grafts
    • Vascular Annual Meeting, Baltimore, MD, June 6-10
    • Dormandy J, Belch J on behalf of the CASPAR investigators. Effect of adding clopidogrel to aspirin on the success of below knee arterial bypass grafts. A randomized placebo controlled study. Vascular Annual Meeting, Baltimore, MD, June 6-10, 2007.
    • (2007) A Randomized Placebo Controlled Study
    • Dormandy, J.1
  • 55
    • 25644457532 scopus 로고    scopus 로고
    • Cilostazol reduced target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery
    • Iida O, Nanto S, Uematsu M, et al. Cilostazol reduced target lesion revascularization after percutaneous transluminal angioplasty in the femoropopliteal artery. Circ J 2005; 69: 1256-9.
    • (2005) Circ J , vol.69 , pp. 1256-1259
    • Iida, O.1    Nanto, S.2    Uematsu, M.3
  • 56
    • 45549101498 scopus 로고    scopus 로고
    • Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions
    • Iida O, Nanto S, Uematsu M, Morozumi T, Kitakaze M, Nagata S. Cilostazol reduces restenosis after endovascular therapy in patients with femoropopliteal lesions. J Vasc Surg 2008; 48: 144-9.
    • (2008) J Vasc Surg , vol.48 , pp. 144-149
    • Iida, O.1    Nanto, S.2    Uematsu, M.3    Morozumi, T.4    Kitakaze, M.5    Nagata, S.6
  • 57
    • 57949090058 scopus 로고    scopus 로고
    • Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication
    • Soga R, Yokoi H, Kawasaki T, et al. Efficacy of cilostazol after endovascular therapy for femoropopliteal artery disease in patients with intermittent claudication. J Am Coll Cardiol 2009; 53: 48-53.
    • (2009) J Am Coll Cardiol , vol.53 , pp. 48-53
    • Soga, R.1    Yokoi, H.2    Kawasaki, T.3
  • 58
    • 0038165393 scopus 로고    scopus 로고
    • A strategy to reduce cardiovascular disease by more than 80%
    • Wald NJ, Law MR. A strategy to reduce cardiovascular disease by more than 80%. BMJ 2003; 326: 1419.
    • (2003) BMJ , vol.326 , pp. 1419
    • Wald, N.J.1    Law, M.R.2
  • 59
    • 34250731233 scopus 로고    scopus 로고
    • Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events)
    • Mukherjee D, Eagle KA, Kline-Rogers E, et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol 2007; 100: 1-6.
    • (2007) Am J Cardiol , vol.100 , pp. 1-6
    • Mukherjee, D.1    Eagle, K.A.2    Kline-Rogers, E.3
  • 60
    • 0035942767 scopus 로고    scopus 로고
    • Medical treatment of peripheral arterial disease and claudication
    • Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344: 1608-21.
    • (2001) N Engl J Med , vol.344 , pp. 1608-1621
    • Hiatt, W.R.1
  • 61
    • 31744451141 scopus 로고    scopus 로고
    • Automated oscillometric determination of the ankle-brachial index provides accuracy necessary for office practice
    • Beckman JA, Higgins CO, Gerhard-Herman M. Automated oscillometric determination of the ankle-brachial index provides accuracy necessary for office practice. Hypertension 2006; 47: 35-8.
    • (2006) Hypertension , vol.47 , pp. 35-38
    • Beckman, J.A.1    Higgins, C.O.2    Gerhard-Herman, M.3
  • 62
    • 0033552883 scopus 로고    scopus 로고
    • Atherosclerosis--an inflammatory disease
    • Ross R. Atherosclerosis--an inflammatory disease. N Engl J Med 1999; 340: 115-26.
    • (1999) N Engl J Med , vol.340 , pp. 115-126
    • Ross, R.1
  • 63
    • 34248173609 scopus 로고    scopus 로고
    • Antiplatelet therapy for atherothrombotic disease: An update for the primary care physician
    • Kikano GE, Brown MT. Antiplatelet therapy for atherothrombotic disease: an update for the primary care physician. Mayo Clin Proc 2007; 82: 583-93.
    • (2007) Mayo Clin Proc , vol.82 , pp. 583-593
    • Kikano, G.E.1    Brown, M.T.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.